Selecta Biosciences, Inc. (SELB) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 17.33M |
| Enterprise Value | -95.13M |
| P/E Ratio | -0.15 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 76.17 |
| Price/Book Ratio | -0.16 |
| Enterprise/Revenue | 16.01 |
| Enterprise/EBITDA | -1.61 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -85.51 |
| Operating Margin | 0 |
| Return On Assets | -0.53 |
| Return On Equity | 1.94 |
| Revenue | 2.8M |
| Revenue/Share | 0.07 |
| Gross Profit | 0 |
| EBITDA | 2.96M |
| Net Income | -130.3M |
| Diluted EPS | -5.02 |
| Total Cash | 118.64M |
| Total Cash/Share | 4.42 |
| Total Debt | 11.86M |
| Total Debt/Equity | -0.08 |
| Current Ratio | 7.65 |
| Book Value Per Share | -5.52 |
| 52-Week Change | -32.73 |
| 52-Week High | 1.99 |
| 52-Week Low | 0.79 |
| Moving Average 50 Days | 1.1 |
| Moving Average 200 Days | 1.19 |
| Average Volume | 634,418 |
| Shares Outstanding | 153.43M |
| % Held by Institutions | 0.04 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |